Skip to main content

Redwood City-based Jasper Therapeutics drops in Wall Street debut

The biotech company's stock opened about 7% below the last price of the special purpose acquisition company it merged with closed in its last day of trading on Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.